Research ArticleOriginal Article
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma
Kishor Mistry and Greg Cable
The Journal of the American Board of Family
Practice March 2003, 16 (2) 95-101; DOI: https://doi.org/10.3122/jabfm.16.2.95

References
- ↵Greenelee RT, Hill-Harmon MB, Murry T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15–36.
- ↵Godley PA. Prostate cancer screening: promise and peril—a review. Cancer Detect Prev 1999; 23: 316–24.
- ↵Jubelirer SJ, Tierney JP, Oliver S, et al. The value of prostatic specific antigen in prostate cancer screening in the community. W Va Med J 1994; 90: 140–2.
- ↵
- ↵Maattanen L, Auvinen A, Stenman UH, et al. European randomized study of prostate cancer screening: first-year results of the Finnish trial. Br J Cancer 1999; 79: 1210–4.
- ↵Kuriyama M, Wang MC, Papsidero LD, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980; 40: 4658–62.
- ↵
- ↵
- ↵Osterling JE. Early detection of prostate cancer. Decreasing the mortality rate. Minn Med 1996; 79: 46–9.
- Guide to clinical preventive services. 2nd ed. Report of the US Preventive Services Task Force. Baltimore, Md: Williams & Wilkins 1996: 119–34.
- Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med 1993; 119: 914–23.
- Woolf HS. Screening for prostate cancer with prostate-specific antigen: an examination of evidence. N Engl J Med 1995; 333: 1401–5.
- ↵Zoorob R, Anderson R, Cefalu C, Sidani M. Cancer screening guidelines. Am J Fam Physician 2001; 63: 1101–12.
- ↵Bangma CH, Kranse R, Blijenberg BG, Schroder F. The value of screening tests in the detection of prostate cancer. Part II: retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density. Urology 1995; 46: 779–84.
- Brett TD. An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice. Fam Pract 1998; 15: 529–33.
- ↵
- Imai K, Ichinose Y, Kubota Y, et al. Clinical significance of prostate specific antigen for early stage prostate cancer detection. Jpn J Clin Oncol 1994; 24: 160–5.
- Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J Urol 1995; 154: 1085–9.
- Reissigl A, Pointner J, Horninger W, et al. PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors. Prostate 1997; 30: 20–5.
- Stenman UH, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostatic specific antigen and its complex with alpha1-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994; 344: 1594–8.
- ↵Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons, 1977: 89–96.
- ↵Woolf HS. Prostate cancer: to screen or not to screen? Commentary. Oncology 1997; 11: 451–2.
- ↵Tornblom M, Norming U, Adolfsson J, et al. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3 ng/mL. Urology 1999; 53: 945–50.
- ↵Lodding P, Aus G, Bergdahl S, et al. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/mL prostate-specific antigen. J Urol 1998; 159: 899–903.
- ↵Svetec D, Thompson IM. PSA screening—current controversy. Ann Oncol 1998; 9: 1283–8.
- ↵Scardino PT. Early detection of prostate cancer. Urol Clin North Am 1989; 16: 635–55.
- ↵Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group. Eur J Cancer 1999; 35: 262–71.
- ↵Zappa M, Ciatto S, Bonardi R, Mazzotta A. Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence screening pilot study. Ann Oncol 1998; 9: 1297–1300.
- ↵Brawer MK. prostate-specific antigen. Diagn Clin Testing 1990; 28: 16–21.
- ↵
- ↵Statistical abstract of the United States. 17th ed. US Department of Commerce, Economics and Statistics Administration, Bureau of the Census. Lantham, Md: Bernan Press, 1997: 15.
- ↵de Koning HJ, Auvinen A, Berenguer Sanchez AB, et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237–44.
In this issue
The Journal of the American Board of Family
Practice
Vol. 16, Issue 2
1 Mar 2003
Meta-Analysis of Prostate-Specific Antigen and Digital Rectal Examination as Screening Tests for Prostate Carcinoma
Kishor Mistry, Greg Cable
The Journal of the American Board of Family
Practice Mar 2003, 16 (2) 95-101; DOI: 10.3122/jabfm.16.2.95
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Caenorhabditis elegans behavioral assay distinguishes early stage prostate cancer patient urine from controls
- Prediction models for prostate cancer to be used in the primary care setting: a systematic review
- Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance
- Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
- Methylation panel is a diagnostic biomarker for Barretts oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
- Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis
- Knowledge and practice of prostate cancer screening among general practitioners in Malaysia: a cross-sectional study
- Combined PET/MRI Improves Diagnostic Accuracy in Patients with Prostate Cancer: A Prospective Diagnostic Trial
- TMPRSS2-ERG Fusion Transcripts in Matched Urine and Needle Rinse Material after Biopsy for the Detection of Prostate Cancer: Really a Step Forward?
- Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
- The liver pharmacological and xenobiotic gene response repertoire